Back to Search Start Over

Cost-effectiveness of a high-intensity versus a low-intensity smoking cessation intervention in a dental setting: long-term follow-up.

Authors :
Feldman I
Helgason AR
Johansson P
Tegelberg Å
Nohlert E
Source :
BMJ open [BMJ Open] 2019 Aug 15; Vol. 9 (8), pp. e030934. Date of Electronic Publication: 2019 Aug 15.
Publication Year :
2019

Abstract

Objectives: The aim of this study was to conduct a cost-effectiveness analysis (CEA) of a high-intensity and a low-intensity smoking cessation treatment programme (HIT and LIT) using long-term follow-up effectiveness data and to validate the cost-effectiveness results based on short-term follow-up.<br />Design and Outcome Measures: Intervention effectiveness was estimated in a randomised controlled trial as numbers of abstinent participants after 1 and 5-8 years of follow-up. The economic evaluation was performed from a societal perspective using a Markov model by estimating future disease-related costs (in Euro (€) 2018) and health effects (in quality-adjusted life-years (QALYs)). Programmes were explicitly compared in an incremental analysis, and the results were presented as an incremental cost-effectiveness ratio.<br />Setting: The study was conducted in dental clinics in Sweden.<br />Participants: 294 smokers aged 19-71 years were included in the study.<br />Interventions: Behaviour therapy, coaching and pharmacological advice (HIT) was compared with one counselling session introducing a conventional self-help programme (LIT).<br />Results: The more costly HIT led to higher number of 6-month continuous abstinent participants after 1 year and higher number of sustained abstinent participants after 5-8 years, which translates into larger societal costs avoided and health gains than LIT. The incremental cost/QALY of HIT compared with LIT amounted to €918 and €3786 using short-term and long-term effectiveness, respectively, which is considered very cost-effective in Sweden.<br />Conclusion: CEA favours the more costly HIT if decision makers are willing to spend at least €4000/QALY for tobacco cessation treatment.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.)

Details

Language :
English
ISSN :
2044-6055
Volume :
9
Issue :
8
Database :
MEDLINE
Journal :
BMJ open
Publication Type :
Academic Journal
Accession number :
31420398
Full Text :
https://doi.org/10.1136/bmjopen-2019-030934